ROYAL BANK OF CANADA - WEREWOLF THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of WEREWOLF THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,000335
+16650.0%
0.00%
Q1 2023$020.0%0.00%
Q4 2022$0
-100.0%
2
-99.5%
0.00%
Q3 2022$2,000
+100.0%
387
+66.1%
0.00%
Q2 2022$1,000
-85.7%
233
-85.6%
0.00%
Q1 2022$7,000
-89.7%
1,622
-71.4%
0.00%
Q4 2021$68,000
+385.7%
5,680
+613.6%
0.00%
Q3 2021$14,000
+55.6%
796
+53.4%
0.00%
Q2 2021$9,0005190.00%
Other shareholders
WEREWOLF THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
DC Funds, LP 589,102$10,274,00048.81%
MPM ASSET MANAGEMENT LLC 4,284,172$74,716,00013.89%
MPM BioImpact LLC 2,388,011$41,647,0006.84%
Soleus Capital Management, L.P. 563,396$9,826,0001.51%
RA Capital Management 4,291,881$74,850,0001.20%
SPHERA FUNDS MANAGEMENT LTD. 706,294$12,049,0000.82%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,552,787$44,521,0000.79%
Nicholas Investment Partners, LP 294,654$5,139,0000.32%
Avidity Partners Management LP 650,265$11,341,0000.31%
PFM Health Sciences, LP 400,000$6,976,0000.22%
View complete list of WEREWOLF THERAPEUTICS INC shareholders